What if pharma just charged less for drugs? Can speaking three syllables reveal whether you’re depressed? And why is Snoop Dogg selling erectile dysfunction pills on TV?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Matthew Herper joins us to discuss a complicated effort from Express Scripts to reduce how much people with diabetes pay for insulin, an idea with broad implications in industry and politics alike. Then, Matt sticks around for a conversation on the controversy surrounding companies like Hims, Roman, and Keeps, which have risen to national attention by selling off-patent drugs without requiring patients to see a doctor. Then, we talk to the CEO of a startup called Sonde Health, which is analyzing voice samples to help develop a smartphone app that could be used to aid in diagnosing depression. Finally, we embark upon a lightning round, summing up the latest dustup for Dr. Patrick Soon-Shiong, a muted meeting of oncologists, and the outgoing FDA commissioner’s seemingly endless farewell tour.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy